Viewing Study NCT05284812


Ignite Creation Date: 2025-12-26 @ 10:17 PM
Ignite Modification Date: 2026-03-02 @ 8:18 AM
Study NCT ID: NCT05284812
Status: SUSPENDED
Last Update Posted: 2023-11-28
First Post: 2022-02-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase Ⅱ Clinical Trial of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)
Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: LKM-2021-BJH01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators